[New High] Korean Kolmar's Stock Soared 71%—So Why Did the Industry Leader Only Rise 10%?

Korean Kolmar's stock is trading around 137,800 won today, climbing back toward its 52-week high of 144,000 won. What's interesting is that Cosmex, which operates in the same cosmetics ODM sector and has larger revenue, saw its stock rise only +10% over the past year, while Korean Kolmar's stock jumped +71% in the same period. I dug into why there's such a temperature gap between companies that manufacture cosmetics on behalf of other brands.

Did the whole sector rise, or is Korean Kolmar just exceptionally strong?

First, I need to check whether this is just Korean Kolmar's story, or if the entire K-beauty ODM sector benefited equally. Looking at the 3-month returns alongside three other companies in the same sector, here's what I see:

· Korean Kolmar +51.1% (1-year +71.0%, P/E 26.0x, Operating Margin 8.8%)

· Cosmekaco Korea +82.2% (1-year +119.5%, P/E 32.2x, Operating Margin 13.0%)

· Cosmex +42.3% (1-year +10.1%, P/E 24.0x, Operating Margin 8.2%)

· C&C International +2.1% (1-year -47.3%, P/E 16.3x, Operating Margin 7.7%)

On a 3-month basis, the median of three companies is +42.3%, but Korean Kolmar has outperformed that. In other words, it's true that the entire sector rode the tailwinds of indie brand exports and rose together, but within that, Korean Kolmar and third-ranked Cosmekaco Korea were exceptionally strong, while first-place Cosmex was relatively subdued. C&C International's solo plunge of -47.3% over a year shows that not everything in this sector automatically goes up.

What happened to make it jump this much?

Q2 operating profit exceeded 110.3 billion won, surpassing 100 billion won for the first time in company history on a quarterly basis. That's a 50% increase from the same period last year. Revenue also rose 17.8% to 861.3 billion won. For the first half, accumulated revenue reached 1.589 trillion won (+14.8%), operating profit 189.2 billion won (+41.8%), and net income 130.6 billion won—double the prior year (Digital Daily, AJU Business Daily). The performance boost came from the summer high season effect, driven by increased overseas expansion of indie brands, which pushed up orders for sunscreen and skincare. The domestic cosmetics market itself isn't growing significantly, but because the brands that outsource to this company are selling more overseas, Kolmar's sales grow accordingly.

Korean Kolmar production line

Brokerages keep raising price targets—isn't it overpriced now?

After the Q2 earnings announcement, price targets were raised in quick succession. KB Securities raised its target to 180,000 won (+38.5% from before), and Hanwha Investment Securities set theirs at 150,000 won (Financial News, High Bulls). Both brokerages set targets above today's close, which suggests the market doesn't see this stock as 'too expensive' right now.

That said, a P/E of 26.0x is higher than first-place Cosmex (24.0x) but lower than third-place Cosmekaco Korea (32.2x)—right in the middle. It's not right to look at this difference simply as 'expensive equals risky.' It's natural that Cosmekaco Korea, with the highest operating margin, commands the highest P/E—while Korean Kolmar, with a lower operating margin (8.8%) than Cosmekaco Korea (13.0%), trades on a premium based on scale and stability. Valuation isn't so much the cause of gains and losses, but rather an amplifier that makes stocks react more dramatically when results are good.

Still, are there any concerns?

By the numbers, there are some soft spots. ROE (return on equity) is 10.1%, which is about half that of peers Cosmex (21.4%) and Cosmekaco Korea (17.2%). The debt-to-equity ratio sits around 107%, which isn't particularly low. Looking purely at the efficiency of earnings relative to equity, it's still lagging behind competitors. On the flip side, foreign ownership rose from 39.29% to 40.95% over the past month, with foreign investors showing consistent net buying. This can be seen as a signal that foreign capital is getting on board with growth backed by real results.

So, what about this stock now?

Korean Kolmar is the stock responding most strongly within a sector-wide uptrend, backed by real earnings power. However, on profitability relative to equity (ROE), it still lags competitors, so both 'there's room for improvement' and 'it hasn't caught up yet' are simultaneously true. There's one key thing to watch going forward. Will operating margins continue to improve above 8% in Q3, or will they fall back once the summer high season ends? If the next quarter's numbers prove it's not just a seasonal spike, then the current strength becomes something backed by fundamentals rather than just narrative.

This article is provided for informational purposes only to assist with investment decisions and does not recommend buying or selling any specific stock.

#한국콜마 #161890 #화장품ODM #K뷰티 #코스맥스 #코스메카코리아 #씨앤씨인터내셔널 #52주신고가 #분기실적 #영업이익 #목표주가 #외국인매수 #ROE #PER #인디브랜드 #선케어 #세종공장 #화장품주 #주식투자 #종목분석